Delirium drug may not benefit critically ill patients, study finds

08/20/2013 | HealthDay News

The antipsychotic drug haloperidol was no more effective than placebo in treating delirium in critically ill patients, according to a study in The Lancet Respiratory Medicine. Researchers tracked 141 seriously ill patients and found that the drug had no effect on length of delirium. Haloperidol also failed to cut death rates, time on ventilators or duration of hospitalization.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY